Minapharm Pharmaceuticals (CAI:MIPH) Days Sales Outstanding : 25.94 (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Days Sales Outstanding?

Minapharm Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2024 was E£430 Mil. Minapharm Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was E£1,513 Mil. Hence, Minapharm Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2024 was 25.94.

The historical rank and industry rank for Minapharm Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

CAI:MIPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.16 Med: 48.22 Max: 49.27
Current: 48.73

During the past 2 years, Minapharm Pharmaceuticals's highest Days Sales Outstanding was 49.27. The lowest was 47.16. And the median was 48.22.

CAI:MIPH's Days Sales Outstanding is ranked better than
74.63% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.17 vs CAI:MIPH: 48.73

Minapharm Pharmaceuticals's Days Sales Outstanding declined from Jun. 2023 (41.64) to Sep. 2024 (25.94).

Minapharm Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Minapharm Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Days Sales Outstanding Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Days Sales Outstanding

49.27

47.16

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial			41.64	-	56.00	38.45	25.94

Competitive Comparison of Minapharm Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Minapharm Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Minapharm Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (488.762	+	517.029)	/	2 )	/	3892.05	*	365
=	502.8955					/	3892.05	*	365
=	47.16

Minapharm Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (395.708	+	464.34)	/	2 )	/	1512.966	*	365 / 4
=	430.024					/	1512.966	*	365 / 4
=	25.94

Minapharm Pharmaceuticals (CAI:MIPH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Minapharm Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines